Abivax 주식 가격. ABVX - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

8.86

매수가

8.50

매도가

8.65

거래량

0.00 일간 변동폭 0.00

0.00 52주 범위 0.00

market_cap

557.449M

전일 종가

8.86

개장가

최근 거래 시간

마지막 거래 시간

재정 규모

VWAP

평균 볼륨(3m)

발행 주식

62,917,479

배당수익률

주가수익률

-3.43

주당순이익(EPS)

-2.35

매출

4.62M

순이익

-147.74M

Abivax is focused on developing innovative treatments that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax is focused on developing innovative treatments that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.abivax.com

본부

Paris, Paris, Fra

설립됨

Abivax SA is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker ABVX. The last closing price for Abivax was US$8.86. Over the last year, Abivax shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Abivax currently has 62,917,479 shares in issue. The market capitalisation of Abivax is US$557.45 million. Abivax has a price to earnings ratio (PE ratio) of -3.43.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq - ABVX) (“Abivax” or the...

Form F-3 - Registration statement by foreign private issuers

Abivax presents third quarter 2024 key financial information

Abivax presents third quarter 2024 key financial information PARIS, France, November 14, 2024, 10:00 p.m. CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax PARIS, France, November 13, 2024, 10:00 pm CET – Abivax SA (Euronext Paris and...

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation PARIS, France, October 7, 2024, 10:00...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

가장 활성
% 상승자
% 패자

기호	가격	볼륨
WORXSCWorx Corporation	US$ 2.11 (115.31%)	9.72M
PETWag Group Company	US$ 0.3142 (49.55%)	12.14M
AKTSAkoustis Technologies Inc	US$ 0.1267 (45.46%)	17.57M
VEEAVeea Inc	US$ 3.67 (30.14%)	1.76M
ISTRInvestar Holding Corporation	US$ 29.99 (28.77%)	7
WSBFWaterstone Financial Inc	US$ 9.00 (-40.98%)	4
TRSTriMas Corporation	US$ 15.62 (-40.79%)	1
BCAXBicara Therapeutics Inc	US$ 11.00 (-40.15%)	101
PYXSPyxis Oncology Inc	US$ 2.43 (-36.39%)	115.35k
XNCRXencor Inc	US$ 15.11 (-36.30%)	2
AKTSAkoustis Technologies Inc	US$ 0.1275 (46.38%)	17.63M
PETWag Group Company	US$ 0.3162 (50.50%)	12.14M
WORXSCWorx Corporation	US$ 2.11 (115.31%)	9.72M
XTKGX3 Holdings Company Ltd	US$ 0.0866 (-3.78%)	9.24M
CRKNCrown Electrokinetics Corporation	US$ 0.9651 (22.84%)	2.64M

Monksdream 2 월 전

ABVX under $15

👍️0

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Abivax SA (ABVX)

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

Abivax SA 정보

ABVX 최신 뉴스

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

Form F-3 - Registration statement by foreign private issuers

Abivax presents third quarter 2024 key financial information

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

Form F-3 - Registration statement by foreign private issuers

Abivax presents third quarter 2024 key financial information

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

이동자

ABVX Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Abivax SA (ABVX) 시세

Abivax SA (ABVX)

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

Abivax SA 정보

ABVX 최신 뉴스

이동자

ABVX Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR